Having the best people means you get the best advice.

Davies Collison Cave boasts an industry leading team that head professional bodies, provide high-level government advice and have proven records as respected advocates.

Why it matters »

Stay informed

Sign up for our quarterly IP Update e-Mag and keep on top of the latest IP news and cases.

Subscribe now »
Read the lastest issue »

Alex Tzanidis | Senior Associate

B.Sc.(Hons.), PhD., MIP Law , Patent and Trade Mark Attorney

Alex Tzanidis

Areas of Expertise

  • Patents
  • Biotechnology
  • Life Sciences
  • Medical Devices
  • Pharmaceuticals

Alex has extensive experience in the preparation and prosecution of patent applications in a wide range of biotechnology-related disciplines, including molecular biology, cell biology, immunology, stem cells, antibody therapeutics, vaccines, medical diagnostics, cardiology, nephrology, angiology and protein fractionation. He assists local clients in developing commercially-focused patent strategies for the global and domestic markets. He also advises clients in contentious and non-contentious patent matters and has extensive experience in patent opposition proceedings.

Alex's PhD studies investigated the role of neurohormonal factors and inflammatory cytokines in the pathophysiology of experimental end stage renal failure. Upon completing his PhD, Alex accepted an invitation to pursue postdoctoral research in the area of cardiovascular disease at the Clinical Pharmacology Unit, Monash Medical School, Alfred Hospital. During this time, he collaborated extensively with research groups at BakerIDI and multinational pharmaceutical companies and has published his work internationally.

Alex gained his attorney qualifications in 2005 and recently joined the Biotechnology practice group of Davies Collison Cave after having worked for another large Australian IP firm. Alex is currently a Fellow of the IPTA Academy of Education and a member of various industry groups.

Alex has experience in handling IP matters relating to many areas of biotechnology, and has assisted local clients, including research institutes, universities and corporate entities, with patent drafting and local/overseas patent prosecution. He also has expertise in overseeing the prosecution of entire Australian and New Zealand patent portfolios for medium to large overseas biotechnology companies.

Affiliations and Memberships

  • Fellow: Institute of Patent and Trade Mark Attorneys of Australia (IPTA)
  • Member: AusBiotech Limited
  • Member: Intellectual Property Society of Australia and New Zealand

Qualifications

  • Bachelor of Science (Hons), Monash University
  • Masters of Intellectual Property Law, Monash University
  • PhD., Monash University
  • Registered Patent and Trade Mark Attorney (Australia and New Zealand)


Alex’s latest articles

Changes to New Zealand Micro-organism Deposit Requirements

The New Zealand Patents Act 2013 came into force on 13 September 2014, raising the patentability and specification… more »

Global Patent Prosecution Highway: a strategy for securing early patent grant

An agreement signed by Australia and 12 other countries will provide applicants with an opportunity to request accelerated… more »

Patenting human embryonic stem cells – European update

 International Stem Cell Corporation v Comptroller General of Patents [2013] EWHC 807 In October 2011, we reported on… more »

Articles about Alex

Changes to New Zealand Micro-organism Deposit Requirements

The New Zealand Patents Act 2013 came into force on 13 September 2014, raising the patentability and specification… more »

Global Patent Prosecution Highway: a strategy for securing early patent grant

An agreement signed by Australia and 12 other countries will provide applicants with an opportunity to request accelerated… more »

DCC hosts BioMelbourne Network Initiatives

DCC continued its support of BioMelbourne Network initiatives by again hosting a lunch in the CEO luncheon forum series on… more »